Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease.
- Resource Type
- Article
- Authors
- Gong, Jiafen; He, Gengming; Wang, Cheng; Bartlett, Claire; Panjwani, Naim; Mastromatteo, Scott; Lin, Fan; Keenan, Katherine; Avolio, Julie; Halevy, Anat; Shaw, Michelle; Esmaeili, Mohsen; Côté-Maurais, Guillaume; Adam, Damien; Bégin, Stéphanie; Bjornson, Candice; Chilvers, Mark; Reisman, Joe; Price, April; Parkins, Michael
- Source
- NPJ Genomic Medicine; 4/8/2022, Vol. 7 Issue 1, p1-15, 15p
- Subject
- Language
- ISSN
- 20567944